EUVIMEDEUVIMED entdecken
Crossref

Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal

Joseph F Goldberg

The Journal of Clinical Psychiatry · 2024

DOI: 10.4088/jcp.23ac15219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, 2024. Verfasst von Joseph F Goldberg. Beteiligte Einrichtung: Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York. Hauptthemen laut MEDLINE: Mood Disorders, Bipolar Disorder.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mood DisordersBipolar DisorderHumansLamotrigineAnticonvulsantsTriazines

Substanzen

LamotrigineAnticonvulsantsTriazines

Autor:innen und Institutionen

  • Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Corresponding Author: Joseph F. Goldberg, MD, 128 East Ave, Norwalk, CT 06851 (joseph.goldberg@mssm.edu).

Zitieren

APA

Goldberg, J. F. (2024). Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.23ac15219

Vancouver

Goldberg JF. Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal. The Journal of Clinical Psychiatry. 2024. doi:10.4088/jcp.23ac15219

BibTeX
@article{Goldberg2024,
  author = {Goldberg, Joseph F},
  title = {Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal},
  journal = {The Journal of Clinical Psychiatry},
  year = {2024},
  doi = {10.4088/jcp.23ac15219}
}
Kostenlos starten →